Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LN”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd. 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Testing effectiveness (Phase 2)UnknownNCT03580291
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Lingyun Sun 230
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Not applicableStudy completedNCT03664908
What this trial is testing

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

Who this might be right for
Lupus Nephritis
CHU de Reims 100
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Not applicableUnknownNCT06210464
What this trial is testing

Disease and Biomarker Profiling of Chinese Lupus Nephritis

Who this might be right for
Characterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to SocIntegrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease EndotypeValidate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring
Nan Shen
Testing effectiveness (Phase 2)Looking for participantsNCT06581198
What this trial is testing

Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals 179
Not applicableStudy completedNCT06559202
What this trial is testing

Inguinal and Axillary LN Size Distribution

Who this might be right for
Lymph Nodes
Gachon University Gil Medical Center 133
Not applicableLooking for participantsNCT04688528
What this trial is testing

Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Universitaire Ziekenhuizen KU Leuven 147
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Not applicableUnknownNCT06288308
What this trial is testing

Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Assiut University 90
Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Early research (Phase 1)Looking for participantsNCT07491900
What this trial is testing

HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)
Hinge Bio 30
Early research (Phase 1)Active Not RecruitingNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Load More Results
100